This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2016-2019.
Company Filing History:
Years Active: 2016-2019
Title: Innovations of Kei Moriyama
Introduction
Kei Moriyama is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds for therapeutic use. His work focuses on creating superior agents for treating central nervous system diseases.
Latest Patents
Moriyama holds two patents, which include a dihydrate of a benzothiophene compound and a process for producing the same. The objective of this invention is to provide a compound that can serve as a more effective therapeutic agent for central nervous system diseases. Specifically, the patent details a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, along with the process for its production.
Career Highlights
He is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is instrumental in advancing therapeutic options for patients with central nervous system disorders.
Collaborations
Some of his notable coworkers include Hiroshi Yamashita and Tetsuya Sato, who collaborate with him on various projects within the company.
Conclusion
Kei Moriyama's contributions to pharmaceutical innovations highlight his commitment to improving therapeutic agents for central nervous system diseases. His patents reflect a dedication to advancing medical science and enhancing patient care.